AbbVie Inc. — Director's Dealing 2017

May 19, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2017-05-18

Reporting Person: CHASE WILLIAM J (EVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-18	Common stock, $0.01 par value	M	25500	$28.86	Acquired	209043	Direct
2017-05-18	Common stock, $0.01 par value	M	12800	$28.13	Acquired	221843	Direct
2017-05-18	Common stock, $0.01 par value	S	38300	$65.35	Disposed	183543	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-05-18	Option (right to buy)	$28.86	M	25500	Disposed	2018-02-14	Common stock (25500)	Direct
2017-05-18	Option (right to buy)	$28.13	M	12800	Disposed	2019-02-19	Common stock (12800)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, $0.01 par value	501	Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of all securities held by his spouse.